NCT05191563

A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects.

An Open-Label, Randomized, Single-Dose Crossover Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 56 (actual)
• Sponsor: Hanmi Pharmaceutical Company Limited · Industry
• Sex: All
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

An Open-Label, Randomized, Single-Dose Crossover Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	HCP1904-1	Take it once per period.
DRUG	RLD2006	Take it once per period.
DRUG	RLD2001-2	Take it once per period.

Timeline

• Start date: 2021-07-31
• Primary completion: 2021-09-12
• Completion: 2021-09-12
• First posted: 2022-01-13
• Last updated: 2022-01-13

Locations

1 site across 1 country: South Korea